Peters GJ - Search Results

1

Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models.

Bergman AM, Adema AD, Balzarini J, Bruheim S, Fichtner I, Noordhuis P, Fodstad O, Myhren F, Sandvold ML, Hendriks HR, Peters GJ. Bergman AM, et al. Among authors: peters gj. Invest New Drugs. 2011 Jun;29(3):456-66. doi: 10.1007/s10637-009-9377-7. Epub 2010 Jan 12. Invest New Drugs. 2011. PMID: 20066470 Free PMC article.

2

Effect of folinic acid on fluorouracil activity and expression of thymidylate synthase.

van der Wilt CL, Pinedo HM, Smid K, Cloos J, Noordhuis P, Peters GJ. van der Wilt CL, et al. Among authors: peters gj. Semin Oncol. 1992 Apr;19(2 Suppl 3):16-25. Semin Oncol. 1992. PMID: 1532671

3

Concentration and time dependent growth inhibition and metabolism in vitro by 2',2'-difluoro-deoxycytidine (gemcitabine).

Ruiz van Haperen VW, Veerman G, Noordhuis P, Vermorken JB, Peters GJ. Ruiz van Haperen VW, et al. Among authors: peters gj. Adv Exp Med Biol. 1991;309A:57-60. doi: 10.1007/978-1-4899-2638-8_12. Adv Exp Med Biol. 1991. PMID: 1789270 No abstract available.

4

Schedule-dependency of in vivo modulation of 5-fluorouracil by leucovorin and uridine in murine colon carcinoma.

Nadal JC, van Groeningen CJ, Pinedo HM, Peters GJ. Nadal JC, et al. Among authors: peters gj. Invest New Drugs. 1989 Jul;7(2-3):163-72. doi: 10.1007/BF00170853. Invest New Drugs. 1989. PMID: 2793368

5

Inhibition of pyrimidine de novo synthesis by DUP-785 (NSC 368390).

Peters GJ, Sharma SL, Laurensse E, Pinedo HM. Peters GJ, et al. Invest New Drugs. 1987;5(3):235-44. doi: 10.1007/BF00175293. Invest New Drugs. 1987. PMID: 2822596

6

Induction of resistance to 2',2'-difluorodeoxycytidine in the human ovarian cancer cell line A2780.

Ruiz van Haperen VW, Veerman G, Eriksson S, Stegmann AP, Peters GJ. Ruiz van Haperen VW, et al. Among authors: peters gj. Semin Oncol. 1995 Aug;22(4 Suppl 11):35-41. Semin Oncol. 1995. PMID: 7481843

7

Schedule-dependent antitumor effect of gemcitabine in in vivo model system.

Braakhuis BJ, Ruiz van Haperen VW, Boven E, Veerman G, Peters GJ. Braakhuis BJ, et al. Among authors: peters gj. Semin Oncol. 1995 Aug;22(4 Suppl 11):42-6. Semin Oncol. 1995. PMID: 7481844

8

Interaction between cisplatin and gemcitabine in vitro and in vivo.

Peters GJ, Bergman AM, Ruiz van Haperen VW, Veerman G, Kuiper CM, Braakhuis BJ. Peters GJ, et al. Semin Oncol. 1995 Aug;22(4 Suppl 11):72-9. Semin Oncol. 1995. PMID: 7481849

9

Importance of pharmacodynamics in the in vitro antiproliferative activity of the antifolates methotrexate and 10-ethyl-10-deazaaminopterin against human head and neck squamous cell carcinoma.

Braakhuis BJ, Jansen G, Noordhuis P, Kegel A, Peters GJ. Braakhuis BJ, et al. Among authors: peters gj. Biochem Pharmacol. 1993 Dec 14;46(12):2155-61. doi: 10.1016/0006-2952(93)90604-u. Biochem Pharmacol. 1993. PMID: 7506025

10

Intermittent continuous infusion of 5-fluorouracil and low dose oral leucovorin in patients with gastrointestinal cancer: relationship between plasma concentrations and clinical parameters.

Poorter RL, Peters GJ, Bakker PJ, Taat CW, Biermans-van Leeuwe DM, Codacci-Pisanelli G, Noordhuis P, Oosting J, Veenhof CH. Poorter RL, et al. Among authors: peters gj. Eur J Cancer. 1995;31A(9):1465-70. doi: 10.1016/0959-8049(95)00217-7. Eur J Cancer. 1995. PMID: 7577073

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

759 results

Search Page